{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:55:28Z","timestamp":1792598128286,"version":"4.5.0"},"reference-count":37,"publisher":"MyJove Corporation","issue":"219","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/67138","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T19:01:02Z","timestamp":1747422062000},"source":"Crossref","is-referenced-by-count":3,"title":["Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats"],"prefix":"10.3791","author":[{"given":"Andrea","family":"Boitnott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Rioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrd.2018.110","type":"journal-article","article-title":"Gene therapy for neurological disorders: Progress and prospects","volume":"17","author":"Deverman","year":"2018","unstructured":"Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M., Sah, D. W. Y. Gene therapy for neurological disorders: Progress and prospects. Nat Rev Drug Discov. 17 (9), 641-659 (2018).","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","type":"journal-article","article-title":"AAV vectors: The Rubik's cube of human gene therapy","volume":"30","author":"Pupo","year":"2022","unstructured":"Pupo, A. et al. AAV vectors: The Rubik's cube of human gene therapy. Mol Ther. 30 (12), 3515-3541 (2022).","journal-title":"Mol Ther"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","type":"journal-article","article-title":"AAV-based in vivo gene therapy for neurological disorders","volume":"22","author":"Ling","year":"2023","unstructured":"Ling, Q., Herstine, J. A., Bradbury, A., Gray, S. J. AAV-based in vivo gene therapy for neurological disorders. Nat Rev Drug Discov. 22 (10), 789-806 (2023).","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s11689-018-9234-0","type":"journal-article","article-title":"Recent progress and considerations for AAV gene therapies targeting the central nervous system","volume":"10","author":"Lykken","year":"2018","unstructured":"Lykken, E. A., Shyng, C., Edwards, R. J., Rozenberg, A., Gray, S. J. Recent progress and considerations for AAV gene therapies targeting the central nervous system. J Neurodev Disord. 10 (1), 16 (2018).","journal-title":"J Neurodev Disord"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1089\/hum.2016.087","type":"journal-article","article-title":"Adeno-associated virus-based gene therapy for CNS diseases","volume":"27","author":"Hocquemiller","year":"2016","unstructured":"Hocquemiller, M., Giersch, L., Audrain, M., Parker, S., Cartier, N. Adeno-associated virus-based gene therapy for CNS diseases. Hum Gene Ther. 27 (7), 478-496 (2016).","journal-title":"Hum Gene Ther"},{"issue":"3-4","key":"ref6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/hum.2022.163","type":"journal-article","article-title":"Biodistribution of adeno-associated virus gene therapy following cerebrospinal fluid-directed administration","volume":"34","author":"Chen","year":"2023","unstructured":"Chen, X. et al. Biodistribution of adeno-associated virus gene therapy following cerebrospinal fluid-directed administration. Hum Gene Ther. 34 (3-4), 94-111 (2023).","journal-title":"Hum Gene Ther"},{"key":"ref7","first-page":"483","type":"journal-article","article-title":"Spinal anesthesia and local medication of the cord","author":"Corning","year":"1885","unstructured":"Corning, J. L. Spinal anesthesia and local medication of the cord. NY Med. J. 483-485 (1885).","journal-title":"NY Med. J"},{"issue":"2-3","key":"ref8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","type":"journal-article","article-title":"Intrathecal morphine in mice: A new technique","volume":"67","author":"Hylden","year":"1980","unstructured":"Hylden, J. L., Wilcox, G. L. Intrathecal morphine in mice: A new technique. Eur J Pharmacol. 67 (2-3), 313-316 (1980).","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0169-409X(03)00101-7","type":"journal-article","article-title":"Spinal delivery of analgesics in experimental models of pain and analgesia","volume":"55","author":"Fairbanks","year":"2003","unstructured":"Fairbanks, C. A. Spinal delivery of analgesics in experimental models of pain and analgesia. Adv Drug Deliv Rev. 55 (8), 1007-1041 (2003).","journal-title":"Adv Drug Deliv Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"109778","DOI":"10.1016\/j.jneumeth.2022.109778","type":"journal-article","article-title":"High-frequency ultrasound-guided intrathecal injections in a young mouse model: Targeting the central nervous system in drug delivery","volume":"386","author":"Choi","year":"2023","unstructured":"Choi, S. E. et al. High-frequency ultrasound-guided intrathecal injections in a young mouse model: Targeting the central nervous system in drug delivery. J Neurosci Methods. 386, 109778 (2023).","journal-title":"J Neurosci Methods"},{"key":"ref11","first-page":"e58565","type":"journal-article","article-title":"Direct intrathecal injection of recombinant adeno-associated viruses in adult mice","volume":"144","author":"Li","year":"2019","unstructured":"Li, D., Li, Y., Tian, Y., Xu, Z., Guo, Y. Direct intrathecal injection of recombinant adeno-associated viruses in adult mice. J Vis Exp. 144, e58565 (2019).","journal-title":"J Vis Exp"},{"key":"ref12","first-page":"e51229","type":"journal-article","article-title":"In vivo SiRNA transfection and gene knockdown in spinal cord via rapid noninvasive lumbar intrathecal injections in mice","volume":"85","author":"Njoo","year":"2014","unstructured":"Njoo, C., Heinl, C., Kuner, R. In vivo SiRNA transfection and gene knockdown in spinal cord via rapid noninvasive lumbar intrathecal injections in mice. J Vis Exp. 85, e51229 (2014).","journal-title":"J Vis Exp"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1744-8069-6-31","type":"journal-article","article-title":"Differential adeno-associated virus-mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture","volume":"6","author":"Vulchanova","year":"2010","unstructured":"Vulchanova, L. et al. Differential adeno-associated virus-mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture. Mol Pain. 6, 31 (2010).","journal-title":"Mol Pain"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","type":"journal-article","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","unstructured":"Yaksh, T. L., Rudy, T. A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 17 (6), 1031-1036 (1976).","journal-title":"Physiol Behav"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/1056-8719(94)90087-6","type":"journal-article","article-title":"A method to perform direct transcutaneous intrathecal injection in rats","volume":"32","author":"Mestre","year":"1994","unstructured":"Mestre, C., Pelissier, T., Fialip, J., Wilcox, G., Eschalier, A. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods. 32 (4), 197-200 (1994).","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref16","first-page":"e66463","type":"journal-article","article-title":"Intrathecal vector delivery in juvenile rats via lumbar cistern injection","volume":"205","author":"Donsante","year":"2024","unstructured":"Donsante, A., Rasmussen, S. A., Fridovich-Keil, J. L. Intrathecal vector delivery in juvenile rats via lumbar cistern injection. J Vis Exp. 205, e66463 (2024).","journal-title":"J Vis Exp"},{"key":"ref17","first-page":"e65761","type":"journal-article","article-title":"Intrathecal injection of newborn mouse for genome editing and drug delivery","volume":"205","author":"Lu","year":"2024","unstructured":"Lu, X., Jiang, Y. H. Intrathecal injection of newborn mouse for genome editing and drug delivery. J Vis Exp. 205, e65761 (2024).","journal-title":"J Vis Exp"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"JCI164575","DOI":"10.1172\/JCI164575","type":"journal-article","article-title":"Intrathecal AAV9\/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies","volume":"133","author":"Chen","year":"2023","unstructured":"Chen, X. et al. Intrathecal AAV9\/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies. J Clin Invest. 133 (10), JCI164575 (2023).","journal-title":"J Clin Invest"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"ijms24119217","DOI":"10.3390\/ijms24119217","type":"journal-article","article-title":"Biochemical correction of GM2 ganglioside accumulation in AB-variant GM2 gangliosidosis","volume":"24","author":"Deschenes","year":"2023","unstructured":"Deschenes, N. M. et al. Biochemical correction of GM2 ganglioside accumulation in AB-variant GM2 gangliosidosis. Int J Mol Sci. 24 (11), ijms24119217 (2023).","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"116392","DOI":"10.1016\/j.biopha.2024.116392","type":"journal-article","article-title":"Specific transcription factors Ascl1 and Lhx6 attenuate diabetic neuropathic pain by modulating spinal neuroinflammation and microglial activation in mice","volume":"173","author":"Hwang","year":"2024","unstructured":"Hwang, S. M., Rahman, M. M., Go, E. J., Kim, Y. H., Park, C. K. Specific transcription factors Ascl1 and Lhx6 attenuate diabetic neuropathic pain by modulating spinal neuroinflammation and microglial activation in mice. Biomed Pharmacother. 173, 116392 (2024).","journal-title":"Biomed Pharmacother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.omtm.2023.07.011","type":"journal-article","article-title":"Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathy","volume":"30","author":"Kagiava","year":"2023","unstructured":"Kagiava, A. et al. Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathy. Mol Ther Methods Clin Dev. 30, 377-393 (2023).","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"169650","DOI":"10.1172\/jci.insight.169650","type":"journal-article","article-title":"CNS-dominant human FMRP isoform rescues seizures, fear, and sleep abnormalities in Fmr1-KO mice","volume":"8","author":"Wong","year":"2023","unstructured":"Wong, H. et al. CNS-dominant human FMRP isoform rescues seizures, fear, and sleep abnormalities in Fmr1-KO mice. JCI Insight. 8 (11), 169650 (2023).","journal-title":"JCI Insight"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1089\/hum.2016.184","type":"journal-article","article-title":"Prevention of neurocognitive deficiency in mucopolysaccharidosis type ii mice by central nervous system-directed, AAV9-mediated iduronate sulfatase gene transfer","volume":"28","author":"Laoharawee","year":"2017","unstructured":"Laoharawee, K. et al. Prevention of neurocognitive deficiency in mucopolysaccharidosis type ii mice by central nervous system-directed, AAV9-mediated iduronate sulfatase gene transfer. Hum Gene Ther. 28 (8), 626-638 (2017).","journal-title":"Hum Gene Ther"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3940(86)90396-4","type":"journal-article","article-title":"Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice","volume":"67","author":"Aanonsen","year":"1986","unstructured":"Aanonsen, L. M., Wilcox, G. L. Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice. Neurosci Lett. 67 (2), 191-197 (1986).","journal-title":"Neurosci Lett"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.omtm.2018.02.005","type":"journal-article","article-title":"Development of intrathecal AAV9 Gene therapy for giant axonal neuropathy","volume":"9","author":"Bailey","year":"2018","unstructured":"Bailey, R. M., Armao, D., Nagabhushan Kalburgi, S., Gray, S. J. Development of intrathecal AAV9 Gene therapy for giant axonal neuropathy. Mol Ther Methods Clin Dev. 9, 160-171 (2018).","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"146832","DOI":"10.1016\/j.brainres.2020.146832","type":"journal-article","article-title":"Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies","volume":"1739","author":"Bailey","year":"2020","unstructured":"Bailey, R. M., Rozenberg, A., Gray, S. J. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies. Brain Res. 1739, 146832 (2020).","journal-title":"Brain Res"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"JCI146286","DOI":"10.1172\/JCI146286","type":"journal-article","article-title":"AAV9\/MFSD8 gene therapy is effective in preclinical models of neuronal ceroid lipofuscinosis type 7 disease","volume":"132","author":"Chen","year":"2022","unstructured":"Chen, X. et al. AAV9\/MFSD8 gene therapy is effective in preclinical models of neuronal ceroid lipofuscinosis type 7 disease. J Clin Invest. 132 (5), JCI146286 (2022).","journal-title":"J Clin Invest"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jnr.23882","type":"journal-article","article-title":"Intrathecal administration of AAV\/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant","volume":"94","author":"Karumuthil-Melethil","year":"2016","unstructured":"Karumuthil-Melethil, S. et al. Intrathecal administration of AAV\/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant. J Neurosci Res. 94 (11), 1138-1151 (2016).","journal-title":"J Neurosci Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.omtm.2021.09.001","type":"journal-article","article-title":"Adeno-associated viral vector serotype 9-based gene replacement therapy for SURF1-related Leigh syndrome","volume":"23","author":"Ling","year":"2021","unstructured":"Ling, Q., Rioux, M., Hu, Y., Lee, M., Gray, S. J. Adeno-associated viral vector serotype 9-based gene replacement therapy for SURF1-related Leigh syndrome. Mol Ther Methods Clin Dev. 23, 158-168 (2021).","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/brain\/awab182","type":"journal-article","article-title":"Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice","volume":"144","author":"Sinnett","year":"2021","unstructured":"Sinnett, S. E., Boyle, E., Lyons, C., Gray, S. J. Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice. Brain. 144 (10), 3005-3019 (2021).","journal-title":"Brain"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"11051413","DOI":"10.3390\/biomedicines11051413","type":"journal-article","article-title":"Epidural and Intrathecal Drug Delivery in Rats and Mice for Experimental Research: Fundamental Concepts, Techniques, Precaution, and Application","volume":"11","author":"Rahman","year":"2023","unstructured":"Rahman, M. M., Lee, J. Y., Kim, Y. H., Park, C. K. Epidural and Intrathecal Drug Delivery in Rats and Mice for Experimental Research: Fundamental Concepts, Techniques, Precaution, and Application. Biomedicines. 11 (5), 11051413 (2023).","journal-title":"Biomedicines"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0749-0704(05)70012-9","type":"journal-article","article-title":"An evidence-based approach to management of increased intracranial pressure","volume":"14","author":"Allen","year":"1998","unstructured":"Allen, C. H., Ward, J. D. An evidence-based approach to management of increased intracranial pressure. Crit Care Clin. 14 (3), 485-495 (1998).","journal-title":"Crit Care Clin"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"604197","DOI":"10.3389\/fnins.2021.604197","type":"journal-article","article-title":"Large-volume intrathecal administrations: Impact on CSF pressure and safety implications","volume":"15","author":"Belov","year":"2021","unstructured":"Belov, V. et al. Large-volume intrathecal administrations: Impact on CSF pressure and safety implications. Front Neurosci. 15, 604197 (2021).","journal-title":"Front Neurosci"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jbiomech.2015.11.012","type":"journal-article","article-title":"Intracranial pressure changes during mouse development","volume":"49","author":"Moazen","year":"2016","unstructured":"Moazen, M. et al. Intracranial pressure changes during mouse development. J Biomech. 49 (1), 123-126 (2016).","journal-title":"J Biomech"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJM196212202672502","type":"journal-article","article-title":"Subarachnoid distribution of drugs after lumbar injection","volume":"267","author":"Rieselbach","year":"1962","unstructured":"Rieselbach, R. E., Di Chiro, G., Freireich, E. J., Rall, D. P. Subarachnoid distribution of drugs after lumbar injection. N Engl J Med. 267, 1273-1278 (1962).","journal-title":"N Engl J Med"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","type":"journal-article","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","unstructured":"Pardridge, W. M. CSF, blood-brain barrier, and brain drug delivery. Expert Opin Drug Deliv. 13 (7), 963-975 (2016).","journal-title":"Expert Opin Drug Deliv"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12987-015-0001-2","type":"journal-article","article-title":"Changes in the cerebrospinal fluid circulatory system of the developing rat: quantitative volumetric analysis and effect on blood-CSF permeability interpretation","volume":"12","author":"Ghersi-Egea","year":"2015","unstructured":"Ghersi-Egea, J. F., Babikian, A., Blondel, S., Strazielle, N. Changes in the cerebrospinal fluid circulatory system of the developing rat: quantitative volumetric analysis and effect on blood-CSF permeability interpretation. Fluids Barriers CNS. 12, 8 (2015).","journal-title":"Fluids Barriers CNS"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/67138\/lumbar-intrathecal-injection-gene-therapy-vectors-for-central-nervous","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:25:31Z","timestamp":1792596331000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/67138\/lumbar-intrathecal-injection-gene-therapy-vectors-for-central-nervous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":37,"journal-issue":{"issue":"219","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/67138","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}